1. Home
  2. KVHI vs ENLV Comparison

KVHI vs ENLV Comparison

Compare KVHI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$11.55

Market Cap

208.4M

Sector

Technology

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.72

Market Cap

196.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
ENLV
Founded
1978
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.4M
196.2M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
KVHI
ENLV
Price
$11.55
$0.72
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
146.1K
236.1K
Earning Date
05-07-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
0.03
N/A
Revenue
$9,622,000.00
N/A
Revenue This Year
$28.90
N/A
Revenue Next Year
$31.85
N/A
P/E Ratio
$358.00
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$0.66
52 Week High
$11.45
$2.10

Technical Indicators

Market Signals
Indicator
KVHI
ENLV
Relative Strength Index (RSI) 66.97 35.04
Support Level $5.56 $0.66
Resistance Level N/A $1.25
Average True Range (ATR) 0.79 0.05
MACD 0.03 0.00
Stochastic Oscillator 96.97 16.31

Price Performance

Historical Comparison
KVHI
ENLV

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: